| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $94.0M | +59.6% | +102.4% |
| Cost of Revenue | $18.2M | +0.9% | +8.9% |
| R&D Expense | $23.7M | -1.9% | -2.0% |
| SG&A Expense | $18.0M | +1.0% | +4.1% |
| Operating Income | $10.3M | +141.1% | +131.5% |
| Interest Expense | $3.0M | +0.8% | +1.1% |
| Net Income | $9.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $55.0M | +27.5% | +44.5% |
| Accounts Receivable | $44.8M | +1.2% | +9.8% |
| Inventory | $9.9M | +18.2% | -16.9% |
| Current Assets | $281.4M | +7.5% | -8.7% |
| Total Assets | $490.6M | -1.2% | -12.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$48.0M | — | — |
| Capital Expenditures | $2.3M | — | — |
| Investing Cash Flow | $46.2M | — | — |
| Financing Cash Flow | $8.7M | — | — |
| Free Cash Flow | -$50.4M | — | — |
| +137.3% |
| +129.8% |
| EPS (Basic) | $0.06 | +135.3% | +127.3% |
| EPS (Diluted) | $0.06 | +135.3% | +127.3% |
| $83.4M |
| -9.5% |
| -4.9% |
| Long-term Debt | $129.4M | -0.8% | -2.5% |
| Total Liabilities | $286.4M | -9.7% | -14.5% |
| Stockholders' Equity | $204.4M | +13.8% | -8.6% |